Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07432087 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07432087
- Sponsor
- Yue He, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2030-12-31
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.